These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15980158)

  • 21. Prognostic significance of Ki-67 and topoisomerase IIalpha expression in infiltrating ductal carcinoma of the breast. A multivariate analysis of 863 cases.
    Rudolph P; MacGrogan G; Bonichon F; Frahm SO; de Mascarel I; Trojani M; Durand M; Avril A; Coindre JM; Parwaresch R
    Breast Cancer Res Treat; 1999 May; 55(1):61-71. PubMed ID: 10472780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
    Santamaria D; Ortega S
    Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
    Chen WJ; Chang CY; Lin JK
    Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.
    Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F
    Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low levels of cell cycle inhibitor p27kip1 combined with high levels of Ki-67 predict shortened disease-free survival in T1 and T2 invasive breast carcinomas.
    Lau R; Grimson R; Sansome C; Tornos C; Moll UM
    Int J Oncol; 2001 Jan; 18(1):17-23. PubMed ID: 11115534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p27Kip1 is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients.
    Stendahl M; Nilsson S; Wigerup C; Jirström K; Jönsson PE; Stål O; Landberg G
    Int J Cancer; 2010 Dec; 127(12):2851-8. PubMed ID: 21351264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer.
    Akli S; Zheng PJ; Multani AS; Wingate HF; Pathak S; Zhang N; Tucker SL; Chang S; Keyomarsi K
    Cancer Res; 2004 May; 64(9):3198-208. PubMed ID: 15126360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of Ki-67 and p27(Kip1) in fine-needle aspirates from breast carcinoma and benign breast diseases.
    Ramljak V; Sučić M; Vrdoljak DV; Borojević N
    Diagn Cytopathol; 2011 May; 39(5):333-40. PubMed ID: 21488176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis.
    Lu X; Toki T; Konishi I; Nikaido T; Fujii S
    Cancer; 1998 Jun; 82(12):2409-17. PubMed ID: 9635534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced expression of Ki-67, topoisomerase IIalpha, PCNA, p53 and p21WAF1/Cip1 reflecting proliferation and repair activity in UV-irradiated melanocytic nevi.
    Rudolph P; Tronnier M; Menzel R; Möller M; Parwaresch R
    Hum Pathol; 1998 Dec; 29(12):1480-7. PubMed ID: 9865836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.
    Tan P; Cady B; Wanner M; Worland P; Cukor B; Magi-Galluzzi C; Lavin P; Draetta G; Pagano M; Loda M
    Cancer Res; 1997 Apr; 57(7):1259-63. PubMed ID: 9102210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast.
    Wong SC; Chan JK; Lee KC; Hsiao WL
    J Pathol; 2001 May; 194(1):35-42. PubMed ID: 11329139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of p21Waf1, p27Kip1 and cyclin D1 proteins in breast ductal carcinoma in situ: Relation with clinicopathologic characteristics and with p53 expression and estrogen receptor status.
    Oh YL; Choi JS; Song SY; Ko YH; Han BK; Nam SJ; Yang JH
    Pathol Int; 2001 Feb; 51(2):94-9. PubMed ID: 11169147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Prognostic Value of G1 Cyclins, p21 and Rb Protein in Patients With Colon Cancer.
    Palaiologos P; Chrysikos D; Theocharis S; Kouraklis G
    Anticancer Res; 2019 Nov; 39(11):6291-6297. PubMed ID: 31704859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between the thymidine labeling and Ki-67 proliferative indices in 126 breast cancer patients.
    Molino A; Pedersini R; Micciolo R; Frisinghelli M; Giovannini M; Pavarana M; Nortilli R; Santo A; Manno P; Padovani M; Piubello Q; Cetto GL
    Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):304-9. PubMed ID: 12607597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.
    Pfister C; Moore L; Allard P; Larue H; Lacombe L; Têtu B; Meyer F; Fradet Y
    Clin Cancer Res; 1999 Dec; 5(12):4079-84. PubMed ID: 10632343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.
    Gray-Bablin J; Rao S; Keyomarsi K
    Cancer Res; 1997 Feb; 57(4):604-9. PubMed ID: 9044834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
    Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y
    Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controversial relationship between the expression of the RB pathway components and RB protein phosphorylation in human breast cancer.
    Montanaro L; Vici M; Donati G; Ceccarelli C; Santini D; Treré D; Derenzini M
    Histol Histopathol; 2007 Jul; 22(7):769-75. PubMed ID: 17455150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of cyclin-dependent kinase inhibitors in leukemia].
    Polák J; Peková S; Schwarz J; Kozák T; Haskovec C
    Cas Lek Cesk; 2003 Jan; 142(1):25-8. PubMed ID: 12693294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.